← FDA Drug Approvals (Drugs@FDA)

LEVOFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT CO INC · Approved 2018-05-25

Drug application

FDA Application #

ANDA205222

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOFLOXACIN

Generic name

LEVOFLOXACIN

Active ingredients

LEVOFLOXACIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

LANNETT CO INC

Manufacturer

Lannett Company, Inc.

First approval

2018-05-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown